Ilyang Pharm Working Capital to Net Assets Ratio
Ilyang Pharm working capital to net assets ratio. Ilyang Pharm (007570) has a Working Capital to Net Assets ratio of -8.5% as of June 2025. Working capital of ₩-20.45 Billion (current assets of ₩139.81 Billion minus current liabilities of ₩160.26 Billion) is measured against net assets of ₩239.41 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Ilyang Pharm (2013–2024)
Working capital to net assets ratio of Ilyang Pharm from 2013 to 2024. This chart shows how Ilyang Pharm's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2013 to 2024. As of June 2025, the ratio stands at -8.5%, reflecting working capital of ₩-20.45 Billion against net assets of ₩239.41 Billion KRW. Explore Ilyang Pharm (007570) long-term investment share to see how much of total assets are deployed in long-term investments.
Ilyang Pharm Working Capital to Net Assets Ratio by Year (2013–2024)
Ilyang Pharm working capital to net assets ratio by year from 2013 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Ilyang Pharm from 2013 to 2024, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 007570 total assets.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -13.1% | ₩-31.53 Billion | ₩241.58 Billion | ₩125.37 Billion | ₩156.90 Billion | ▼ -0.3 pp |
| 2023 | -12.7% | ₩-24.99 Billion | ₩196.41 Billion | ₩114.20 Billion | ₩139.19 Billion | ▼ -17.5 pp |
| 2022 | 4.8% | ₩13.87 Billion | ₩291.85 Billion | ₩200.73 Billion | ₩186.86 Billion | ▲ +2.8 pp |
| 2021 | 2.0% | ₩5.35 Billion | ₩271.76 Billion | ₩203.56 Billion | ₩198.21 Billion | ▲ +8.0 pp |
| 2020 | -6.0% | ₩-14.65 Billion | ₩244.92 Billion | ₩162.50 Billion | ₩177.15 Billion | ▼ -2.0 pp |
| 2019 | -4.0% | ₩-8.92 Billion | ₩222.74 Billion | ₩171.41 Billion | ₩180.33 Billion | ▲ +6.6 pp |
| 2018 | -10.6% | ₩-22.31 Billion | ₩209.88 Billion | ₩161.38 Billion | ₩183.69 Billion | ▲ +8.6 pp |
| 2017 | -19.2% | ₩-40.57 Billion | ₩210.98 Billion | ₩166.14 Billion | ₩206.71 Billion | ▼ -3.2 pp |
| 2016 | -16.0% | ₩-34.76 Billion | ₩217.35 Billion | ₩147.67 Billion | ₩182.43 Billion | ▼ -1.2 pp |
| 2015 | -14.8% | ₩-31.27 Billion | ₩211.00 Billion | ₩146.84 Billion | ₩178.11 Billion | ▼ -9.2 pp |
| 2014 | -5.6% | ₩-10.35 Billion | ₩183.46 Billion | ₩158.52 Billion | ₩168.87 Billion | ▲ +3.4 pp |
| 2013 | -9.0% | ₩-16.59 Billion | ₩183.88 Billion | ₩129.81 Billion | ₩146.40 Billion | — |